Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

[Early recognition and screening consultation: a necessary way to improve early detection and treatment in rheumatology? : Overview of the early recognition and screening consultation models for rheumatic and musculoskeletal diseases in Germany].

Benesova K, Lorenz HM, Lion V, Voigt A, Krause A, Sander O, Schneider M, Feuchtenberger M, Nigg A, Leipe J, Briem S, Tiessen E, Haas F, Rihl M, Meyer-Olson D, Baraliakos X, Braun J, Schwarting A, Dreher M, Witte T, Assmann G, Hoeper K, Schmidt RE, Bartz-Bazzanella P, Gaubitz M, Specker C.

Z Rheumatol. 2019 Oct;78(8):722-742. doi: 10.1007/s00393-019-0683-y. Review. German.

PMID:
31468170
2.

[Osteoporosis-frequent comorbidity in patients with rheumatism].

Gaubitz M.

Z Rheumatol. 2019 Apr;78(3):249-254. doi: 10.1007/s00393-019-0622-y. Review. German.

PMID:
30911837
3.

[Etanercept in routine German clinical practice to treat rheumatoid arthritis patients : A one-year observational study on effectiveness, safety and health economics].

Gaubitz M, Lippe R, Göttl KH, Lüthke K, Klopsch T, Meng T, Behmer O, Löschmann PA.

Z Rheumatol. 2019 Aug;78(6):552-558. doi: 10.1007/s00393-018-0536-0. German.

PMID:
30684031
4.

Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.

Heiligenhaus A, Minden K, Tappeiner C, Baus H, Bertram B, Deuter C, Foeldvari I, Föll D, Frosch M, Ganser G, Gaubitz M, Günther A, Heinz C, Horneff G, Huemer C, Kopp I, Lommatzsch C, Lutz T, Michels H, Neß T, Neudorf U, Pleyer U, Schneider M, Schulze-Koops H, Thurau S, Zierhut M, Lehmann HW.

Semin Arthritis Rheum. 2019 Aug;49(1):43-55. doi: 10.1016/j.semarthrit.2018.11.004. Epub 2018 Dec 4. Review.

5.

[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs].

Fiehn C, Holle J, Iking-Konert C, Leipe J, Weseloh C, Frerix M, Alten R, Behrens F, Baerwald C, Braun J, Burkhardt H, Burmester G, Detert J, Gaubitz M, Gause A, Gromnica-Ihle E, Kellner H, Krause A, Kuipers J, Lorenz HM, Müller-Ladner U, Nothacker M, Nüsslein H, Rubbert-Roth A, Schneider M, Schulze-Koops H, Seitz S, Sitter H, Specker C, Tony HP, Wassenberg S, Wollenhaupt J, Krüger K.

Z Rheumatol. 2018 Aug;77(Suppl 2):35-53. doi: 10.1007/s00393-018-0481-y. Review. German.

PMID:
29968101
6.

Etanercept is effective as monotherapy or in combination with methotrexate in rheumatoid arthritis: subanalysis of an observational study.

Gaubitz M, Göttl KH, Behmer O, Lippe R, Meng T, Löschmann PA.

Clin Rheumatol. 2017 Sep;36(9):1989-1996. doi: 10.1007/s10067-017-3757-8. Epub 2017 Jul 30.

PMID:
28756532
7.

Interleukin-6 promoter haplotypes are associated with etanercept response in patients with rheumatoid arthritis.

Schotte H, Schmidt H, Gaubitz M, Drynda S, Kekow J, Willeke P, Schlüter B.

Clin Rheumatol. 2015 Dec;34(12):2021-8. doi: 10.1007/s10067-015-3107-7. Epub 2015 Nov 3.

PMID:
26526676
8.

Putative IL-10 Low Producer Genotypes Are Associated with a Favourable Etanercept Response in Patients with Rheumatoid Arthritis.

Schotte H, Schlüter B, Schmidt H, Gaubitz M, Drynda S, Kekow J, Willeke P.

PLoS One. 2015 Jun 24;10(6):e0130907. doi: 10.1371/journal.pone.0130907. eCollection 2015.

9.

Efficacy and safety of nicoboxil/nonivamide ointment for the treatment of acute pain in the low back - A randomized, controlled trial.

Gaubitz M, Schiffer T, Holm C, Richter E, Pisternick-Ruf W, Weiser T.

Eur J Pain. 2016 Feb;20(2):263-73. doi: 10.1002/ejp.719. Epub 2015 Apr 30.

10.

Comparison of tocilizumab and tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective analysis of 1603 patients managed in routine clinical practice.

Backhaus M, Kaufmann J, Richter C, Wassenberg S, Roske AE, Hellmann P, Gaubitz M.

Clin Rheumatol. 2015 Apr;34(4):673-81. doi: 10.1007/s10067-015-2879-0. Epub 2015 Jan 29.

11.

[Arthralgia plus positive treatment of rheumatoid arthritis - yes].

Gaubitz M.

Dtsch Med Wochenschr. 2014 Sep;139(37):1842. doi: 10.1055/s-0034-1387235. Epub 2014 Sep 2. German. No abstract available.

PMID:
25181000
12.

[Diagnosis and treatment of Lyme arthritis. Recommendations of the Pharmacotherapy Commission of the Deutsche Gesellschaft für Rheumatologie (German Society for Rheumatology)].

Gaubitz M, Dressler F, Huppertz HI, Krause A; Kommission Pharmakotherapie der DGRh.

Z Rheumatol. 2014 Jun;73(5):469-74. doi: 10.1007/s00393-014-1370-7. German.

PMID:
24924733
13.

[Recommendations for use of abatacept in patients with rheumatoid arthritis].

Gaubitz M, Krüger K, Haas JP; Die Kommission Pharmakotherapie der DGRh.

Z Rheumatol. 2014 Dec;73(10):942-9. doi: 10.1007/s00393-014-1373-4. German. No abstract available.

PMID:
24903655
14.

Association of extended interleukin-10 promoter haplotypes with disease susceptibility and manifestations in German patients with systemic lupus erythematosus.

Schotte H, Willeke P, Becker H, Poggemeyer J, Gaubitz M, Schmidt H, Schlüter B.

Lupus. 2014 Apr;23(4):378-85. doi: 10.1177/0961203314522334. Epub 2014 Feb 17.

PMID:
24536045
15.

Diagnostic classification based on functional connectivity in chronic pain: model optimization in fibromyalgia and rheumatoid arthritis.

Sundermann B, Burgmer M, Pogatzki-Zahn E, Gaubitz M, Stüber C, Wessolleck E, Heuft G, Pfleiderer B.

Acad Radiol. 2014 Mar;21(3):369-77. doi: 10.1016/j.acra.2013.12.003.

PMID:
24507423
16.

German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.

Albrecht K, Krüger K, Wollenhaupt J, Alten R, Backhaus M, Baerwald C, Bolten W, Braun J, Burkhardt H, Burmester GR, Gaubitz M, Gause A, Gromnica-Ihle E, Kellner H, Kuipers J, Krause A, Lorenz HM, Manger B, Nüßlein H, Pott HG, Rubbert-Roth A, Schneider M, Specker C, Schulze-Koops H, Tony HP, Wassenberg S, Müller-Ladner U; German Society of Rheumatology.

Rheumatol Int. 2014 Jan;34(1):1-9. doi: 10.1007/s00296-013-2848-3. Epub 2013 Aug 14. Review.

PMID:
23942828
17.

[German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm].

Krüger K, Wollenhaupt J, Albrecht K, Alten R, Backhaus M, Baerwald C, Bolten W, Braun J, Burkhardt H, Burmester G, Gaubitz M, Gause A, Gromnica-Ihle E, Kellner H, Kuipers J, Krause A, Lorenz HM, Manger B, Nüßlein H, Pott HG, Rubbert-Roth A, Schneider M, Specker C, Schulze-Koops H, Tony HP, Wassenberg S, Müller-Ladner U; European League of Associations for Rheumatology (EULAR).

Z Rheumatol. 2012 Sep;71(7):592-603. doi: 10.1007/s00393-012-1038-0. German.

PMID:
22930110
18.

[Biologicals 2012].

Gaubitz M.

Orthopade. 2012 Jul;41(7):526-32. doi: 10.1007/s00132-012-1931-x. German.

PMID:
22752258
19.

Rituximab effectively reduces macrophage migration inhibitory factor in patients with active rheumatoid arthritis.

Willeke P, Becker H, Schlüter B, Pavenstäd H, Mickholz E, Wierichs C, Gaubitz M, Schotte H.

Scand J Rheumatol. 2012 May;41(3):242-3. doi: 10.3109/03009742.2012.654817. Epub 2012 Mar 9. No abstract available.

PMID:
22401537
20.

Cerebral mechanisms of experimental hyperalgesia in fibromyalgia.

Burgmer M, Pfleiderer B, Maihöfner C, Gaubitz M, Wessolleck E, Heuft G, Pogatzki-Zahn E.

Eur J Pain. 2012 May;16(5):636-47. doi: 10.1002/j.1532-2149.2011.00058.x. Epub 2011 Dec 19.

PMID:
22337349
21.

Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.

Heiligenhaus A, Michels H, Schumacher C, Kopp I, Neudorf U, Niehues T, Baus H, Becker M, Bertram B, Dannecker G, Deuter C, Foeldvari I, Frosch M, Ganser G, Gaubitz M, Gerdes G, Horneff G, Illhardt A, Mackensen F, Minden K, Pleyer U, Schneider M, Wagner N, Zierhut M; German Ophthalmological Society; Society for Childhood and Adolescent Rheumatology; German Society for Rheumatology.

Rheumatol Int. 2012 May;32(5):1121-33. doi: 10.1007/s00296-011-2126-1. Epub 2011 Nov 15. Review.

PMID:
22083610
22.

Cerebral activation and catastrophizing during pain anticipation in patients with fibromyalgia.

Burgmer M, Petzke F, Giesecke T, Gaubitz M, Heuft G, Pfleiderer B.

Psychosom Med. 2011 Nov-Dec;73(9):751-9. doi: 10.1097/PSY.0b013e318236588a. Epub 2011 Nov 2.

PMID:
22048836
23.

Assessment of long-term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis.

Klareskog L, Gaubitz M, Rodríguez-Valverde V, Malaise M, Dougados M, Wajdula J; Etanercept Study 301 Investigators.

Clin Exp Rheumatol. 2011 Mar-Apr;29(2):238-47. Epub 2011 Apr 19.

PMID:
21418785
24.

[Recommendations of the German rheumatology society on the use of tocilizumab in rheumatoid arthritis].

Gause A, Rubbert-Roth A, Michels H, Gaubitz M, Mayet WJ; Kommission Pharmakotherapie der DGRh.

Z Rheumatol. 2010 Jun;69(4):365-72. doi: 10.1007/s00393-010-0612-6. German.

PMID:
20495924
25.

Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

Distler O, Eich W, Dokoupilova E, Dvorak Z, Fleck M, Gaubitz M, Hechler M, Jansen JP, Krause A, Bendszus M, Pache L, Reiter R, Müller-Ladner U.

Arthritis Rheum. 2010 Jan;62(1):291-300. doi: 10.1002/art.25062.

26.

Fibromyalgia unique temporal brain activation during experimental pain: a controlled fMRI Study.

Burgmer M, Pogatzki-Zahn E, Gaubitz M, Stüber C, Wessoleck E, Heuft G, Pfleiderer B.

J Neural Transm (Vienna). 2010 Jan;117(1):123-31. doi: 10.1007/s00702-009-0339-1. Epub 2009 Nov 25.

PMID:
19937376
27.

[Recommendations on therapy using interleukin-1beta-blocking agents].

Manger B, Gaubitz M, Michels H; Kommission Pharmakotherapie der DGRh; German Society of Rheumatology.

Z Rheumatol. 2009 Nov;68(9):766-71. doi: 10.1007/s00393-009-0542-3. German.

PMID:
19756659
28.

[How to deal with suspected rheumatoid arthritis at an early stage].

Gaubitz M.

MMW Fortschr Med. 2009 Jul 23;151(30-33):47-9. German. No abstract available.

PMID:
19722463
29.

Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia.

Burgmer M, Gaubitz M, Konrad C, Wrenger M, Hilgart S, Heuft G, Pfleiderer B.

Psychosom Med. 2009 Jun;71(5):566-73. doi: 10.1097/PSY.0b013e3181a32da0. Epub 2009 May 4.

PMID:
19414621
30.

Clinical image: Lupus erythematosus cells in ascites fluid.

Krug U, Buchner T, Fassbinder T, Gaubitz M, Berdel WE.

Arthritis Rheum. 2009 Mar;60(3):859. doi: 10.1002/art.24359. No abstract available.

31.

[Leg ulcer in mixed connective tissue disease. Resolution during sitaxsentan therapy].

Becker H, Sunderkoetter C, Willeke P, Domschke W, Gaubitz M, Mohr M.

Z Rheumatol. 2009 Mar;68(2):154-6. doi: 10.1007/s00393-008-0421-3. German.

PMID:
19156432
32.

Altered brain activity during pain processing in fibromyalgia.

Burgmer M, Pogatzki-Zahn E, Gaubitz M, Wessoleck E, Heuft G, Pfleiderer B.

Neuroimage. 2009 Jan 15;44(2):502-8. doi: 10.1016/j.neuroimage.2008.09.008. Epub 2008 Sep 24.

PMID:
18848998
33.

Etanercept tolerance in a patient with previous infliximab-induced hepatitis.

Becker H, Willeke P, Domschke W, Gaubitz M.

Clin Rheumatol. 2008 Dec;27(12):1597-8. doi: 10.1007/s10067-008-1000-3. Epub 2008 Sep 16. No abstract available.

PMID:
18795397
34.

Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study.

Combe B, Codreanu C, Fiocco U, Gaubitz M, Geusens PP, Kvien TK, Pavelka K, Sambrook PN, Smolen JS, Khandker R, Singh A, Wajdula J, Fatenejad S; Etanercept European Investigators Network.

Ann Rheum Dis. 2009 Jul;68(7):1146-52. doi: 10.1136/ard.2007.087106. Epub 2008 Sep 15.

35.

[Recommedations for the use of abatacept in patients with rheumatoid arthritis].

Krüger K, Gaubitz M; Kommission Pharmakotherapie der DGRh.

Z Rheumatol. 2008 Nov;67(7):614-6. doi: 10.1007/s00393-008-0347-9. German. No abstract available.

PMID:
18719926
36.

Potential role of macrophage migration inhibitory factor in adult-onset Still's disease.

Becker H, Gaubitz M, Domschke W, Willeke P.

Scand J Rheumatol. 2009 Jan-Feb;38(1):69-71. doi: 10.1080/03009740802179701. No abstract available.

PMID:
18686192
37.

Macrophage migration inhibitory factor may contribute to vasculopathy in systemic sclerosis.

Becker H, Willeke P, Schotte H, Domschke W, Gaubitz M.

Clin Rheumatol. 2008 Oct;27(10):1307-11. doi: 10.1007/s10067-008-0960-7. Epub 2008 Jul 11.

PMID:
18618071
38.

The role of interleukin-10 promoter polymorphisms in primary Sjogren's syndrome.

Willeke P, Gaubitz M, Schotte H, Becker H, Domschke W, Schlüter B.

Scand J Rheumatol. 2008 Jul-Aug;37(4):293-9. doi: 10.1080/03009740801910353.

PMID:
18612930
39.

Interferon-gamma is increased in patients with primary Sjogren's syndrome and Raynaud's phenomenon.

Willeke P, Schlüter B, Schotte H, Domschke W, Gaubitz M, Becker H.

Semin Arthritis Rheum. 2009 Dec;39(3):197-202. doi: 10.1016/j.semarthrit.2008.04.002. Epub 2008 Jun 24.

PMID:
18571695
40.

Increased risk of myeloid leukaemia in patients with ankylosing spondylitis following treatment with radium-224.

Wick RR, Nekolla EA, Gaubitz M, Schulte TL.

Rheumatology (Oxford). 2008 Jun;47(6):855-9. doi: 10.1093/rheumatology/ken060. Epub 2008 Apr 4.

PMID:
18390588
41.

Pedography and radiographic imaging for the detection of foot deformities in rheumatoid arthritis.

Schmiegel A, Vieth V, Gaubitz M, Rosenbaum D.

Clin Biomech (Bristol, Avon). 2008 Jun;23(5):648-52. Epub 2007 Nov 19.

PMID:
18022297
42.

Mycophenolate sodium treatment in patients with primary Sjögren syndrome: a pilot trial.

Willeke P, Schlüter B, Becker H, Schotte H, Domschke W, Gaubitz M.

Arthritis Res Ther. 2007;9(6):R115.

43.

Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome.

Willeke P, Gaubitz M, Schotte H, Maaser C, Domschke W, Schlüter B, Becker H.

Arthritis Res Ther. 2007;9(2):R43.

44.

Prompt response of refractory Schnitzler syndrome to treatment with anakinra.

Schneider SW, Gaubitz M, Luger TA, Bonsmann G.

J Am Acad Dermatol. 2007 May;56(5 Suppl):S120-2. No abstract available.

PMID:
17434038
45.

Assessment of foot impairment in rheumatoid arthritis patients by dynamic pedobarography.

Schmiegel A, Rosenbaum D, Schorat A, Hilker A, Gaubitz M.

Gait Posture. 2008 Jan;27(1):110-4. Epub 2007 Apr 6.

PMID:
17419061
46.

Gastrointestinal bleeding secondary to hepatic artery involvement of microscopic polyangiitis: case report and review of the literature.

Spahn TW, Ullerich HJ, Lebitz P, Wormanns D, Gaubitz M, Mueller MK, Domschke W.

Dig Dis Sci. 2007 Jun;52(6):1558-61. Epub 2007 Apr 5. Review. No abstract available.

PMID:
17410468
47.

Epidemiology of connective tissue disorders.

Gaubitz M.

Rheumatology (Oxford). 2006 Oct;45 Suppl 3:iii3-4. Review. Erratum in: Rheumatology (Oxford). 2008 Feb;47(2):234-5.

PMID:
16987829
48.

Clinical and immunological characteristics of patients with Sjögren's syndrome in relation to alpha-fodrin antibodies.

Willeke P, Gaubitz M, Schotte H, Becker H, Mickholz E, Domschke W, Schlüter B.

Rheumatology (Oxford). 2007 Mar;46(3):479-83. Epub 2006 Aug 25.

PMID:
16935916
49.

[Joint involvement in chronic inflammatory bowel disease--current diagnostics and treatment options].

Becker H, Gaubitz M, Domschke W, Kucharzik T.

Z Gastroenterol. 2006 Jun;44(6):497-502. Review. German.

PMID:
16773516
50.

Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison.

Combe B, Codreanu C, Fiocco U, Gaubitz M, Geusens PP, Kvien TK, Pavelka K, Sambrook PN, Smolen JS, Wajdula J, Fatenejad S; Etanercept European Investigators Network (Etanercept Study 309 Investigators).

Ann Rheum Dis. 2006 Oct;65(10):1357-62. Epub 2006 Apr 10.

Supplemental Content

Loading ...
Support Center